Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company’s lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate. STSA $6.8400 -0.4800 % -6.5600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend […]
Read MoreAkero Therapeutics, Inc. (AKRO) Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company’s lead product candidate is efruxifermin (EFX). Brainstorm Cell Therapeutics Inc. (BCLI) Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of […]
Read MoreSatsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. STSA $6.9200 0.4200 % 6.4600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.46% Wk: 7.96% Mo: 17.29% Yrly: 45.07% YTD: 53.78% Strength Rank: […]
Read MoreMilestone Pharmaceuticals Inc. (MIST) Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker. Cogent Biosciences, Inc. (COGT) Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective […]
Read MoreiRhythm Technologies, Inc. (IRTC) iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor. Weatherford International plc (WFRD) Weatherford International plc, an energy services company, […]
Read MoreCogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal […]
Read MoreBuy Price: $12.30 or better Sell Price: TradersPro Sell Signal BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of […]
Read MoreCogent Biosciences, Inc. (COGT) Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis. Scorpio Tankers Inc. (STNG) Scorpio Tankers Inc., together with its subsidiaries, engages in the […]
Read MoreImperial Oil Limited (IMO) Imperial Oil Limited engages in exploration, production, and sale of crude oil and natural gas in Canada. The company operates through three segments: Upstream, Downstream and Chemical segments. The Upstream segment explores for, and produces crude oil, natural gas, synthetic oil, and bitumen. Option Care Health, Inc. (OPCH) Option Care Health, […]
Read MoreTrevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. TRVI $3.9100 0.2800 % 7.7100 Trevi Therapeutics Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 7.71% Wk: 27.78% Mo: -1.01% Yrly: 96.48% […]
Read MoreBuy Price: $3.00 or better Sell Price: TradersPro Sell Signal Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The stocks founds in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal trend. Suggested […]
Read MoreBuy Price: $21.50 or better Sell Price: TradersPro Sell Signal Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein. The stocks founds in the One […]
Read MoreBuy Price: $4.20 or better Sell Price: TradersPro Sell Signal Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine. The stocks founds in the One Hot Stock category use stocks that are in long […]
Read MoreVoyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company’s lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson’s disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis. VYGR $6.6200 -0.2400 % […]
Read MoreMeridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. VIVO $32.5000 -0.0200 % -0.0600 Meridian Bioscience Sector : Medical Industry : Medical Products Signal Short Term Trend […]
Read More